Retrospective Study on Anosmias and Ageusias Linked to Infection by Covid-19 (STras-Cov-2)

December 23, 2020 updated by: University Hospital, Strasbourg, France

Retrospective Study on Anosmias and Ageusias Linked to Infection by SARS-Cov 2

Odor and taste disturbances have increased dramatically during this time of the COVID-19 pandemic. Currently, we have very little information on the demographic and clinical characteristics of the affected population, on the severity and course of the olfactory / taste loss.

The main objective of this research is to analyze the epidemiological, demographic and clinical characteristics of patients suspected or already confirmed of infection with SARS-Cov2 presenting with anosmia and / or ageusia.

Study Overview

Status

Unknown

Conditions

Covid-19

Study Type

Observational

Enrollment (Anticipated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

France
- Starsbourg
  - Strasbourg, Starsbourg, France, 67091
    - Recruiting
    - Strasbourg University Hospitals - Otorhino-Laryngology Department
    - Sub-Investigator:
      
      François LEFEBVRE, MD
    - Sub-Investigator:
      
      Guillaume TRAU, MD
    - Sub-Investigator:
      
      Christian DEBRY, MD, PhD
    - Contact:
      
      Marion RENAUD, MD
      
      Phone Number: 33 3 88 12 61 89
      
      Email: marion.renaud@chru-strasbourg.fr
    - Principal Investigator:
      
      Marion RENAUD, MD
    - Sub-Investigator:
      
      Alexandra LEON, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adult patient having had a loss of smell and / or taste that occurred during the period of the Covid-19 epidemic with or without other symptom (s) suggestive of a Covid infection -19

Description

Inclusion Criteria:

Major subject (≥18 years old)
Subject having had a loss of smell and / or taste that occurred during the period of the Covid-19 epidemic with or without other symptom (s) suggestive of a Covid infection -19
Subject with suspected or confirmed Covid-19 infection
Subject taken care of by the ENT service
Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.

Exclusion Criteria:

Subject having expressed opposition to participating in the study
Subject under guardianship or guardianship
Subject under safeguard of justice

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Retrospective analysis of demographic and clinical characteristics of patients with suspected or already confirmed SARS-Cov2 infection with anosmia and / or ageusia Time Frame: The files analysed retrospectily from February 01, 2020 to June 03, 2020 will be examined]	The files analysed retrospectily from February 01, 2020 to June 03, 2020 will be examined]

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Strasbourg, France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 3, 2020

Primary Completion (Anticipated)

April 3, 2021

Study Completion (Anticipated)

April 3, 2021

Study Registration Dates

First Submitted

December 22, 2020

First Submitted That Met QC Criteria